House: Accompanied a new draft, see H4943
Summary
The bill requires that a wide range of health insurance plans in Massachusetts—state employee plans, Medicaid‑managed care, private accident or sickness policies, group and hospital service plans, and health maintenance contracts—cover FDA‑approved epinephrine auto‑injectors and equivalent pre‑filled syringes at the appropriate weight‑based dose. These plans cannot impose higher deductibles, coinsurance, copays, or out‑of‑pocket limits on the injectors than on any other prescription drug. The goal is to make life‑saving allergy medication affordable and accessible for all insured residents.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when H 1206 changes status, plus AI-powered summaries and stage predictions.
Sign up free